iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
10.03
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM
10.03
0.05%
After-hours: May 30, 2025, 04:25 PM EDT
0.00% (1D)
| Bid | 9.86 |
| Market Cap | 383.69M |
| Revenue (ttm) | 35M |
| Net Income (ttm) | -130.81M |
| EPS (ttm) | -3.05 |
| PE Ratio (ttm) | -3.29 |
| Forward PE | -4.08 |
| Analyst | Hold |
| Ask | 10.14 |
| Volume | 1,527,110 |
| Avg. Volume (20D) | 1,144,520 |
| Open | 10.00 |
| Previous Close | 10.03 |
| Day's Range | 9.88 - 10.13 |
| 52-Week Range | 4.80 - 18.13 |
| Beta | 1.39 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
+17.94%
ITeos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
2 weeks ago
+13.44%
ITeos Therapeutics shares are trading higher after the company reported topline interim results from its GALAXIES Lung-201 study of Belrestotug + Dostarlimab.
